NewsBenzingaOcugen Executes Licensing Agreement With Roots Pharma And Its Strategic Partner Al-Dhow International For Exclusive Rights To OCU400 For Treatment Of Retinitis Pigmentosa In Middle East And North Africa Region Ocugen Executes Licensing Agreement With Roots Pharma And Its Strategic Partner Al-Dhow International For Exclusive Rights To OCU400 For Treatment Of Retinitis Pigmentosa In Middle East And North Africa Region Benzinga 2026.10.14 10:32 (GMT+0) Open on Benzinga Other news UBS Maintains Buy on GE Aerospace, Raises Price Target to $380 Pinnacle Finl Partners Q3 Adj. EPS $2.69 Beats $2.63 Estimate, Sales $1.312B Beat $1.283B Estimate Microsoft Says China-Aligned Hackers Used AI To Accelerate ConnectWise Supply-Chain Attack Across Hundreds Of Organizations Canada's PM Carney Says We Will See If Cleveland-Cliffs CEO Is Acting In Good Faith; Carney, Asked Why Canada Is Not Suing Cleveland-Cliffs, Says There Is A Legal Process To Be Followed; Says Company Can Still Respect Its Commitments Citigroup Maintains Buy on Netflix, Lowers Price Target to $85 Ex-Google CEO Eric Schmidt Says AI Could Eliminate 20% of Jobs at Large Companies
Microsoft Says China-Aligned Hackers Used AI To Accelerate ConnectWise Supply-Chain Attack Across Hundreds Of Organizations
Canada's PM Carney Says We Will See If Cleveland-Cliffs CEO Is Acting In Good Faith; Carney, Asked Why Canada Is Not Suing Cleveland-Cliffs, Says There Is A Legal Process To Be Followed; Says Company Can Still Respect Its Commitments
